Merz Therapeutics names Dan Staner as president, Region Europe

Germany’s Merz Therapeutics today announced the appointment of Dan Staner as president, region Europe, effective February 1. In this role, he will oversee the company’s European business and drive regional growth.

Mr Staner will report directly to Merz Therapeutics chief executive Stefan König, and will join the executive team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​

“Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, adding: “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​